Bafna Pharmaceuticals Ltd

  • BSE Code : 532989
  • NSE Symbol : BAFNAPH
  • ISIN : INE878I01022
  • Industry :PHARMACEUTICALS - INDIAN - FORMULATIONS

up-arrow 111.32 -0.64(-0.57%)

Open Price ()

111.96

Prev. Close ()

111.96

Volume (No’s)

1,830

Market Cap ()

263.34

Low Price ()

109.55

High Price ()

115.00

 

Corporate Announcement

27-Mar-2026 Bafna Pharmaceuticals Limited - Outcome of Board Meeting
24-Mar-2026 Bafna Pharmaceuticals Limited - Price movement
26-Dec-2025 Bafna Pharmaceuticals Limited - Trading Window
14-Nov-2025 Bafna Pharmaceuticals Limited - Copy of Newspaper Publication
11-Nov-2025 Bafna Pharmaceuticals Limited - Outcome of Board Meeting

Stock Summary

Market Cap(₹Cr.)

262.59

P/E (TTM)

22.93

Book value ()

38.56

Div Yield (%)

0

EPS (TTM)

4.84

Face Value ()

10.00

Technical Analysis

Key Level

Resistance 1

113.91

Resistance 2

115.85

Support 1

110.91

Support 2

109.85

Moving Average

30 Days

111.47

50 Days

114.50

100 Days

134.58

200 Days

123.09

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Bafna Pharmaceuticals Ltd 262.59 22.93 2.09 11.77 0 4.84
Sun Pharmaceutical Indust.. 406,603.30 93.16 17.11 7162.05 0.94 18.19
Divis Laboratories Ltd 155,484.95 60.44 10.27 3332 0.51 96.91
Torrent Pharmaceuticals L.. 135,009.27 60.45 14.42 3583.06 0.15 65.99
Lupin Ltd 104,090.54 18.82 3.81 5569.31 0.53 120.95

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of Returns(%)

in Months Ago

My investment would be worth with a Loss of

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 2337173 9.88
Total Institutions 0 0.00
Total Govt Holding 0 0.00
Total Non Promoter Corporate Holding 586042 2.48
Total Promoters 17742251 75.00
Total Public & others 2990869 12.65
Total 23656335 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Bafna Pharmaceuticals Limited (BPL) was started as a proprietary concern in 1981 by Mr. Bafna Mahaveer Chand in the name of Bafna Pharmaceutical and is engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non Betalactum products. The first manufacturing unit was set up at Madhavaram (Chennai) during October 1984 for manufacture of tablets with an installed capacity of 420 lacs tablets p.a. Subsequently the capsule line was added during 1987 with a capacity of 300 lacs capsule p.a. and then liquid line with an installed capacity of 45000 lts p.a was added in 1990.

Bafna Pharmaceuticals, incorporated in 1995, had acquired the entire business of the proprietary concern. During the year 2001, the company constructed a separate block at Madhavaram for manufacturing Betalactum products. During 2006, Bafna has set up a 100% EOU unit at Madhavaram for the production of tablets and capsule with a capacity of 6973.20 lacs and 2462.40 lacs. This facility has been set up as per revised Schedule M under the Drugs and Cosmetics Act, 1947.

Bafna was carrying on contract manufacturing for M/s Croslands Pvt. Ltd, a Mumbai based Pharmaceutical Company during the period 1994 to 2000. The company's first product was registered in Srilanka in 1995 and the company made...

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew